» Articles » PMID: 35298439

14-3-3ζ Constrains Insulin Secretion by Regulating Mitochondrial Function in Pancreatic β Cells

Abstract

While critical for neurotransmitter synthesis, 14-3-3 proteins are often assumed to have redundant functions due to their ubiquitous expression, but despite this assumption, various 14-3-3 isoforms have been implicated in regulating metabolism. We previously reported contributions of 14-3-3ζ in β cell function, but these studies were performed in tumor-derived MIN6 cells and systemic KO mice. To further characterize the regulatory roles of 14-3-3ζ in β cell function, we generated β cell-specific 14-3-3ζ-KO mice. Although no effects on β cell mass were detected, potentiated glucose-stimulated insulin secretion (GSIS), mitochondrial function, and ATP synthesis were observed. Deletion of 14-3-3ζ also altered the β cell transcriptome, as genes associated with mitochondrial respiration and oxidative phosphorylation were upregulated. Acute 14-3-3 protein inhibition in mouse and human islets recapitulated the enhancements in GSIS and mitochondrial function, suggesting that 14-3-3ζ is the critical isoform in β cells. In dysfunctional db/db islets and human islets from type 2 diabetic donors, expression of Ywhaz/YWHAZ, the gene encoding 14-3-3ζ, was inversely associated with insulin secretion, and pan-14-3-3 protein inhibition led to enhanced GSIS and mitochondrial function. Taken together, this study demonstrates important regulatory functions of 14-3-3ζ in the regulation of β cell function and provides a deeper understanding of how insulin secretion is controlled in β cells.

Citing Articles

Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity.

Katz L, Visser E, Plitzko K, Pennings M, Cossar P, Tse I Nat Commun. 2025; 16(1):2110.

PMID: 40025013 PMC: 11873037. DOI: 10.1038/s41467-025-57241-7.


Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells.

Ruiz-Pino A, Goncalves-Ramirez A, Jimenez-Palomares M, Merino B, Castellano-Munoz M, Vettorazzi J Pflugers Arch. 2024; 477(2):207-221.

PMID: 39601887 DOI: 10.1007/s00424-024-03045-5.


Plasma proteomics in children with new-onset type 1 diabetes identifies new potential biomarkers of partial remission.

Polle O, Pyr Dit Ruys S, Lemmer J, Hubinon C, Martin M, Herinckx G Sci Rep. 2024; 14(1):20798.

PMID: 39242727 PMC: 11379901. DOI: 10.1038/s41598-024-71717-4.


The Development of CDC25A-Derived Phosphoseryl Peptides That Bind 14-3-3ε with High Affinities.

Kamayirese S, Maity S, Hansen L, Lovas S Int J Mol Sci. 2024; 25(9).

PMID: 38732131 PMC: 11084659. DOI: 10.3390/ijms25094918.


Structural Features and Physiological Associations of Human 14-3-3ζ Pseudogenes.

Lughmani H, Patel H, Chakravarti R Genes (Basel). 2024; 15(4).

PMID: 38674334 PMC: 11049341. DOI: 10.3390/genes15040399.


References
1.
Mugabo Y, Sadeghi M, Fang N, Mayor T, Lim G . Elucidation of the 14-3-3ζ interactome reveals critical roles of RNA-splicing factors during adipogenesis. J Biol Chem. 2018; 293(18):6736-6750. PMC: 5936800. DOI: 10.1074/jbc.M117.816272. View

2.
Yong J, Parekh V, Reilly S, Nayak J, Chen Z, Lebeaupin C . / depletion in β cells alleviates ER stress and corrects hepatic steatosis in mice. Sci Transl Med. 2021; 13(604). PMC: 8557800. DOI: 10.1126/scitranslmed.aba9796. View

3.
Xing H, Zhang S, Weinheimer C, Kovacs A, Muslin A . 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 2000; 19(3):349-58. PMC: 305572. DOI: 10.1093/emboj/19.3.349. View

4.
Diallo K, Oppong A, Lim G . Can 14-3-3 proteins serve as therapeutic targets for the treatment of metabolic diseases?. Pharmacol Res. 2018; 139:199-206. DOI: 10.1016/j.phrs.2018.11.021. View

5.
Lim G, Johnson J . 14-3-3ζ: A numbers game in adipocyte function?. Adipocyte. 2016; 5(2):232-7. PMC: 4916895. DOI: 10.1080/21623945.2015.1120913. View